Ningbo David Medical Device Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Ningbo David Medical Device Co., Ltd. carries a market capitalization of 2.91B, placing it among publicly traded companies globally. Its enterprise value stands at 3.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.91B |
| Enterprise Value | 3.03B |
Share Statistics
Ningbo David Medical Device Co., Ltd. currently has 288.00M shares outstanding.
| Shares Outstanding | 288.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Ningbo David Medical Device Co., Ltd. trades at a trailing price-to-earnings ratio of 59.24. The price-to-sales ratio is 7.13, and the price-to-book ratio stands at 3.94.
| PE Ratio | 59.24 |
| PS Ratio | 7.13 |
| PB Ratio | 3.94 |
| P/TBV Ratio | 3.18 |
| P/FCF Ratio | 36.77 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Ningbo David Medical Device Co., Ltd. trades at an EV/EBITDA multiple of 44.15 and an EV/FCF ratio of 30.37. The EV/Sales ratio of 5.92 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 44.15 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.92 |
| EV / EBITDA | 44.15 |
| EV / EBIT | 44.15 |
| EV / FCF | 30.37 |
Financial Position
Ningbo David Medical Device Co., Ltd. maintains a current ratio of 4.17, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.62, indicating moderate leverage, while an interest coverage ratio of 154.52 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.17 |
| Quick Ratio | 2.94 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 0.11 |
| Interest Coverage | 154.52 |
Financial Efficiency
Ningbo David Medical Device Co., Ltd. posts a return on equity of 6.77 and a return on invested capital of 5.20.
| Return on Equity (ROE) | 6.77 |
| Return on Assets (ROA) | 4.44 |
| Return on Invested Capital (ROIC) | 5.20 |
| Return on Capital Employed (ROCE) | 6.74 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.18 |
Taxes
Over the trailing twelve months, Ningbo David Medical Device Co., Ltd. has paid 6.90M in income taxes, reflecting an effective tax rate of 10.06.
| Income Tax | 6.90M |
| Effective Tax Rate | 10.06 |
Stock Price Statistics
Ningbo David Medical Device Co., Ltd.'s stock has declined approximately -20.90838% over the past 52 weeks. The 50-day moving average sits at 11.85, while the 200-day moving average is 13.32.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20.90838% |
| 50-Day Moving Average | 11.85 |
| 200-Day Moving Average | 13.32 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Ningbo David Medical Device Co., Ltd. generated 512.46M in revenue and converted that into 61.71M in net income, yielding earnings per share of 0.21. EBITDA reached 68.65M, while operating income came in at 68.65M.
| Revenue | 512.46M |
| Gross Profit | 289.61M |
| Operating Income | 68.65M |
| Pretax Income | 68.61M |
| Net Income | 61.71M |
| EBITDA | 68.65M |
| EBIT | 68.65M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
Ningbo David Medical Device Co., Ltd. holds 631.93M in cash and equivalents against 7.43M in total debt, resulting in a net debt position of -356.93M. Total book value stands at 928.71M, with working capital of 680.56M providing operational flexibility.
| Cash & Cash Equivalents | 631.93M |
| Total Debt | 7.43M |
| Net Debt | -356.93M |
| Equity (Book Value) | 928.71M |
| Book Value Per Share | 3.23 |
| Working Capital | 680.56M |
Cash Flow
After subtracting -99.41M in capital expenditures, free cash flow totaled -99.41M - equivalent to -0.35 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -99.41M |
| Free Cash Flow | -99.41M |
| FCF Per Share | -0.35 |
Margins
Ningbo David Medical Device Co., Ltd. operates with a gross margin of 56.51, reflecting its pricing power and cost economics. The operating margin of 13.40 and net profit margin of 12.04 provide insight into operational efficiency.
| Gross Margin | 56.51 |
| Operating Margin | 13.40 |
| Pretax Margin | 13.39 |
| Profit Margin | 12.04 |
| EBITDA Margin | 13.40 |
Dividends & Yields
The company's payout ratio of 55.49 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.12 |
| Dividend Yield | N/A |
| Payout Ratio | 55.49 |
| Shareholder Yield | 0.98 |
| FCF Yield | 2.72 |
Stock Splits
Ningbo David Medical Device Co., Ltd.'s most recent stock split took place on May 20, 2015 with a 5:9 split ratio.
| Last Split Date | 5/20/2015 |
| Split Ratio | 5:9 |
Scores
Ningbo David Medical Device Co., Ltd. posts an Altman Z-Score of 11.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.61 |